Suppr超能文献

外周动脉疾病伴或不伴并存慢性阻塞性肺疾病的全身炎症:选定标志物分析。

Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.

机构信息

Department of Internal Medicine, Pulmonology and Allergology, Medical University of Warsaw, Poland.

出版信息

Arch Med Sci. 2012 Jul 4;8(3):477-83. doi: 10.5114/aoms.2012.29403.

Abstract

INTRODUCTION

Low-grade systemic inflammation plays an important role in the pathogenesis and natural history of chronic obstructive pulmonary disease (COPD) and peripheral arterial disease (PAD). The aim of the study was to analyze plasma concentrations of selected markers of inflammation in patients suffering from PAD with or without coexistent COPD.

MATERIAL AND METHODS

Thirty patients (6 women) with advanced PAD (at least IIb stage according to Fontaine scale) hospitalized due to critical limb ischemia were examined. In all patients spirometry was performed to confirm or exclude COPD. Plasma concentration of IL-6, IL-8 and TNF-α was measured using ELISA method. Statistical analysis was performed according to COPD status and according to smoking status independently.

RESULTS

In the whole group of patients with PAD, COPD was recognized in 14 cases (for the first time in 10 cases). All patients were smokers (46.7% current, 53.3% ex-smokers). We found a significant correlation between FEV1%N (percent of norm of first second expiratory volume) and the number of years of smoking (r = -0.39; p < 0.05). We found similar concentrations of IL-6 (2.54 pg/ml vs. 2.31 pg/ml), IL-8 (8.55 pg/ml vs. 8.14 pg/ml, TNF-α (0.72 pg/ml vs. 1.75 pg/ml) in the COPD(+) group in comparison to the COPD(-) group (differences were not significant). We observed significant positive correlations (p < 0.05) between concentrations of measured markers and significant negative correlations between pain free walking distance and these markers.

CONCLUSIONS

Our study confirmed coexistence of PAD with COPD. The character of inflammation is similar in these smoking-related diseases.

摘要

简介

低度全身炎症在慢性阻塞性肺疾病(COPD)和外周动脉疾病(PAD)的发病机制和自然史中起着重要作用。本研究的目的是分析患有 PAD 合并或不合并 COPD 的患者的炎症标志物血浆浓度。

材料与方法

检查了 30 名(6 名女性)因严重肢体缺血而住院的晚期 PAD 患者(根据 Fontaine 量表至少为 IIb 期)。所有患者均进行了肺量测定以确认或排除 COPD。使用 ELISA 法测量 IL-6、IL-8 和 TNF-α 的血浆浓度。根据 COPD 状态和吸烟状态分别进行统计分析。

结果

在所有 PAD 患者中,有 14 例(首次在 10 例中)被诊断为 COPD。所有患者均为吸烟者(46.7% 当前吸烟者,53.3% 戒烟者)。我们发现 FEV1%N(第一秒呼气量占正常百分比)与吸烟年限之间存在显著相关性(r = -0.39;p <0.05)。我们发现 COPD(+) 组与 COPD(-) 组的 IL-6(2.54 pg/ml 对 2.31 pg/ml)、IL-8(8.55 pg/ml 对 8.14 pg/ml)和 TNF-α(0.72 pg/ml 对 1.75 pg/ml)浓度相似(差异无统计学意义)。我们观察到测量标志物浓度之间存在显著正相关(p <0.05),并且无疼痛行走距离与这些标志物之间存在显著负相关。

结论

我们的研究证实了 PAD 与 COPD 的共存。这些与吸烟有关的疾病的炎症特征相似。

相似文献

4
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Immunol Lett. 2018 Apr;196:1-10. doi: 10.1016/j.imlet.2018.01.004. Epub 2018 Jan 9.
6
8
Systemic inflammation in COPD in relation to smoking status.
Multidiscip Respir Med. 2011 Aug 31;6(4):214-9. doi: 10.1186/2049-6958-6-4-214.
9
Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2017 Aug 11;12:2407-2415. doi: 10.2147/COPD.S141805. eCollection 2017.
10
Systemic inflammation in patients with COPD and pulmonary hypertension.
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.

引用本文的文献

1
Tissue metabolomic profiling to reveal the therapeutic mechanism of reduning injection on LPS-induced acute lung injury rats.
RSC Adv. 2018 Mar 13;8(18):10023-10031. doi: 10.1039/c7ra13123b. eCollection 2018 Mar 5.
2
The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis.
Ann Am Thorac Soc. 2022 Apr;19(4):625-632. doi: 10.1513/AnnalsATS.202105-547OC.
3
Oxygen dependence of endothelium-dependent vasodilation: importance in chronic obstructive pulmonary disease.
Arch Med Sci. 2018 Mar;14(2):297-306. doi: 10.5114/aoms.2016.58854. Epub 2016 Mar 24.
5
Lower extremity and carotid artery disease in COPD.
ERJ Open Res. 2016 Oct 26;2(4). doi: 10.1183/23120541.00037-2016. eCollection 2016 Oct.
6
Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease.
Arch Med Sci. 2016 Apr 1;12(2):279-87. doi: 10.5114/aoms.2015.50757. Epub 2016 Apr 12.
9
Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia.
Arch Med Sci. 2015 Apr 25;11(2):325-31. doi: 10.5114/aoms.2013.39935. Epub 2014 Jul 23.
10
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease.
Arch Med Sci. 2014 Oct 27;10(5):920-32. doi: 10.5114/aoms.2014.46212. Epub 2014 Oct 23.

本文引用的文献

2
Serum interleukin-6 levels in colorectal cancer patients--a summary of published results.
Int J Colorectal Dis. 2010 Feb;25(2):135-40. doi: 10.1007/s00384-009-0818-8. Epub 2009 Nov 7.
4
Exercise as a mean to control low-grade systemic inflammation.
Mediators Inflamm. 2008;2008:109502. doi: 10.1155/2008/109502. Epub 2009 Jan 11.
5
Chronic obstructive pulmonary disease in patients admitted with heart failure.
J Intern Med. 2008 Oct;264(4):361-9. doi: 10.1111/j.1365-2796.2008.01975.x. Epub 2008 Jun 5.
6
Systemic inflammation, genetic susceptibility and lung function.
Eur Respir J. 2008 Jul;32(1):92-7. doi: 10.1183/09031936.00052507. Epub 2008 Apr 2.
7
Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.
Respirology. 2008 Jan;13(1):128-33. doi: 10.1111/j.1440-1843.2007.01170.x.
8
Complex chronic comorbidities of COPD.
Eur Respir J. 2008 Jan;31(1):204-12. doi: 10.1183/09031936.00114307.
9
Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.
Proc Am Thorac Soc. 2007 Dec;4(8):626-34. doi: 10.1513/pats.200706-071TH.
10
Risk factor awareness in patients with peripheral arterial disease.
J Cardiovasc Surg (Torino). 2007 Dec;48(6):735-40.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验